Given that both STAT3 and NF-κB are the substrate of SMYD2 in several tumor cells and kidney cyst epithelial cells (Li et al., 2017), we suggest that methylation of STAT3 and NF-κB by SMYD2 may promote cisplatin-induced AKI. The gene discussed is SMYD2; the disease is neoplasm.